Vnitr Lek 2005, 51(2):238-243

Treatment of chronic infection with hepatitis C virus with pegylated interferon and ribavirin in patient with mixed cryoglobulinaemia

P. Husa1,*, Z. Adam2, L. Husová3, J. Feit4, M. Penka5, Z. Čermáková6
1 Klinika infekčních chorob Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta doc. MUDr. Petr Husa, CSc.
2 Interní hematoonkologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Jiří Vorlíček, CSc.
3 Interní gastroenterologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Petr Dítě, DrSc.
4 Patologicko-anatomický ústav Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Jirka Mačák, CSc.
5 Oddělení klinické hematologie FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Miroslav Penka, CSc.
6 Oddělení klinické biochemie a hematologie FN Brno, pracoviště Bohunice, přednosta doc. MUDr. Milan Dastych, CSc.

Mixed cryoglobulinaemia is the most common extrahepatic manifestation of hepatitis C virus (HCV) infection. Anti-HCV antibodies and ribonucleic acid of the virus, HCV RNA, can be detected in cryoprecipitates, together with rheumatoid factor. Cryoglobulins consist of complex of immunoglobulins that in vitro precipitate upon the cooling bellow the human body temperature. Vasculitis is caused by the deposition of such immunocomplexes in the small blood vessels. 36-45% of patients chronically infected with HCV have cryoglobulins in serum; however, less than 10% of them develop clinically manifested vasculitis. In the referred patient sporadic eruption of exanthema with urticaria pattern started to appear on both lower limbs concurrently with sole oedemas and migrating arthralgias in 1998. He was examined by a lot of specialists without the cause of exanthema being found. Only after 5 years chronic hepatitis C was diagnosed, infection with genotype 2 of the virus, and the relationship between skin manifestations belonging to the clinical picture of vasculitis associated with type 3 mixed cryoglobulinaemia and chronic HCV infection was found. Patient was treated for 24 weeks with pegylated interferon alpha-2a and ribavirin. During a treatment period HCV RNA disappeared from serum and skin findings became normal. This situation persists even 48 weeks after the end of the antiviral treatment.

Keywords: chronic hepatitis C; mixed cryoglobulinaemia; pegylated interferon; ribavirin

Received: March 22, 2004; Accepted: April 23, 2004; Published: February 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Husa P, Adam Z, Husová L, Feit J, Penka M, Čermáková Z. Treatment of chronic infection with hepatitis C virus with pegylated interferon and ribavirin in patient with mixed cryoglobulinaemia. Vnitr Lek. 2005;51(2):238-243.
Download citation

References

  1. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327(21): 1490-1495. Go to original source... Go to PubMed...
  2. Cacoub P, Lidove O, Maisonobe T et al. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis and Rheumatism 2002; 46(12): 3317-3326. Go to original source... Go to PubMed...
  3. Calleja JL, Albillos A, Moreno-Otero R et al. Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia. Aliment Pharmacol Ther 1999; 13(9): 1179-1186. Go to original source... Go to PubMed...
  4. Cicardi M, Cesana B, Del Ninno E et al. Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C. J Viral Hepatol 2000; 7(2): 138-143. Go to original source... Go to PubMed...
  5. Durand JM, Cacoub P, Lunel-Fabiani F et al. Ribavirin in hepatitis C related cryoglobulinemia. J Rheumatol 1998; 25(6): 1115-1117. Go to PubMed...
  6. Ferri C, Marzo E, Longobardo G et al. Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood 1993; 81(5): 1132-1136. Go to original source...
  7. Hoofnagle JH, Heller T. Hepatitis C. In: Zakim D, Boyer TD (eds). Hepatology. A Textbook of Liver Disease. 4th ed. Philadelphia: WB Saunders 2003; 1017-1062.
  8. Ito A, Kazama T, Ito K et al. Purpura with cold urticaria in a patient wit hepatitis C virus infection-associated mixed cryoglobulinemia type III: successful treatment with interferon beta. J Dermatol 2003; 30(4): 321-325. Go to original source... Go to PubMed...
  9. Lamprecht P, Lerin-Lozano C, Merz H et al. Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis. Ann Rheum Dis 2003; 62(12): 1230-1233. Go to original source... Go to PubMed...
  10. Lunel F, Cacoub P. Treatment of autoimmune and extrahepatic manifestations of hepatitis C virus infection. J Hepatol 1999; 31(Suppl 1): 210-216. Go to original source... Go to PubMed...
  11. Mazzaro C, Colle R, Baracetti S et al. Effectiveness of leukocyte interferon in patients affected by HCV-positive mixed cryoglobulinemia resistant to recombinant alpha-interferon. Clin Exper Rheumatol 2002; 20(1): 27-34.
  12. Mazzaro C, Zorat F, Comar C et al. Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon. J Rheumatol 2003; 30(8): 1775-1781. Go to PubMed...
  13. Misiani R, Bellavita P, Fenili D et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117(7): 573-577. Go to original source... Go to PubMed...
  14. Misiani R, Bellavita P, Fenili D et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330(11): 751-756. Go to original source... Go to PubMed...
  15. Pascual M, Perrin L, Giostra E et al. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990; 162(2): 569-570. Go to original source... Go to PubMed...
  16. Pawlotsky JM, Ben Yahia M, Andre C et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19(4): 841-848. Go to original source... Go to PubMed...
  17. Schott P, Hartmann H, Ramadori G. Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanism of cryoprecipitation and options of treatment. Histology and Histopathology 2001; 16(4): 1275-1285. Go to PubMed...
  18. Zuckerman E, Keren D, Slobodin G et al. Treatment of refractory, symptomatic hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha. J Rheumatol 2000; 27(8): 2172-2178. Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.